Home pfizer
 

Keywords :   


Tag: pfizer

Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer

2015-04-29 05:17:09| drugdiscoveryonline Home Page

Pfizer Inc. announced recently that XALKORI (crizotinib) received Breakthrough Therapy designation by the U.S

Tags: cell treatment cancer patients

 

Pfizer, despite dollar and generics fight, still impresses

2015-04-28 20:51:37| Biotech - Topix.net

Cost-cutting and sales of new drugs helped Pfizer overcome a strong dollar and patent expirations to beat Wall Street projections for the first quarter, though it cut its outlook for the year, citing the unfavorable currency exchange rates. The world's second-biggest drugmaker on Tuesday said its 2015 profit forecast includes a negative impact of $3.3 billion from currency exchange, and another $3.5 billion from generic competition.

Tags: still fight dollar pfizer

 
 

Pfizer Tops Street 1Q Forecasts

2015-04-28 14:27:12| Biotech - Topix.net

The New York-based company said it had profit of 38 cents per share. Earnings, adjusted for non-recurring costs, were 51 cents per share.

Tags: street tops forecasts pfizer

 

Pfizer wins first U.S. trial over Zoloft birth-defect risk

2015-04-18 07:04:07| Biotech - Topix.net

Pfizer Inc scored a key victory Friday when it was cleared of liability in the first U.S. trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant. Plaintiff Kristyn Pesante claimed that Pfizer failed to warn that using Zoloft during pregnancy could cause birth defects and sought damages after her son was born with a rare, serious congenital heart problem.

Tags: trial risk wins zoloft

 

Approved Pfizer breast cancer drug impresses in latest study

2015-04-16 12:55:11| Biotech - Topix.net

Pfizer Inc said on Wednesday the first formal late-stage trial of its approved treatment for advanced breast cancer, Ibrance, was stopped early after the medicine met its goal of delaying progression of the disease in previously treated patients. J.P.Morgan analyst Chris Schott said in a research note that the successful trial results should boost demand for the recently approved treatment, which works differently than approved medicines and has blockbuster sales potential.

Tags: latest study approved drug

 

Sites : [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »